Archive
BT investors 'flying blind' as it reports first quarter results without net adds
Jefferies reckons the key focus for BT's quarterly results will be on the business and public sector division following a poor performance last year
Company
Hutchmed (China) Ltd
LON:HCM
Hutchmed (China) Ltd is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery, global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. A dedicated organization of over 1,400 personnel has advanced eleven cancer drug candidates from in-house discovery into clinical studies around the world, with its first three oncology drugs now approved
62 stories · page 2 of 4
Hutchison China Meditech starts US proof-of-concept trial for key cancer drug
The Phase Ib/II study is for people suffering from pancreatic neuroendocrine tumours (NET) and biliary tract cancer (BTC)
Archive
Apres moi le deluge: Flood of blue chip results to dominate in coming week, including BT Group
Over the five sessions in the Week Ahead, around 20% of the FTSE 100 index will report results or issue a trading update, with about half that number due on Thursday alone
Archive
Momentum investing: Use the Force, Luke
A lot of academic research suggests a momentum investing strategy outperforms the market. John Harrington attempts to concoct a lazy person's momentum investing system.
Hutchison China Meditech looks to first drug approval this year
Simon To, chairman, said: "In our Innovation Platform, we have progressed our deep portfolio of eight clinical drug candidates"
Investments and investor services
FTSE 100 can’t hold gains and closes in red as sterling firms
Britain's blue-chip benchmark closed down over nine points, or 0.13% to 7,214..
Archive
Banks to dominate another busy earnings week, including numbers from HSBC and RBS
Week ahead: HSBC, Royal Bank of Scotland, Royal Dutch Shell, Next, Centrica, Shire, US jobs, Bank of England policy meeting ...
Hutchison China MediaTech reports record 2016 revenue as commercial sales rise
The biopharma company said it has made progress on the development of several cancer treatments
Archive
Antofagasta closing in on a feasibility study of expansion of Los Pelambres
Big names reporting include Antofagasta, Hikma and Robert Walters.